Developing Self-Management Interventions After HCT

Completed

Conditions studied: Hematopoietic Stem Cell Transplant (HSCT)

In brief

This is a prospective, longitudinal, observational trial to evaluate quality of life in hematopoietic stem cell transplant survivors.

Key facts

Study ID

NCT03710031

Run by

University of Florida

People needed

49

Starts

2019-02-04

Expected to finish

2021-07-31

Last updated by the study team

2021-09-09

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• patients scheduled for HSCT with the Bone Marrow Transplant Program at the UF Health Cancer Center (UFHCC) [specifically bone marrow diseases, myelodysplastic-myeloproliferative diseases, lymphoma, bone marrow neoplasm or leukemia]
• Written informed consent obtained from the subject to take Mini-Mental State Examination (MMSE) prior to enrollment on the study and to comply with all the study-related procedures.
• Score at least a 24 on the Mini-Mental State Examination (MMSE) prior to enrollment

You may not qualify if…

• Subjects with any of the following will not be eligible for study participation:
• Patient has prior history of HSCT
• Patient has diagnosis that could interfere with neurocognitive function such as dementia, a concurrent diagnosis of systemic lupus erythematous or multiple sclerosis, diagnosis of a major depressive disorder, schizophrenia or untreated bipolar disease.
• Pregnant women are not eligible for transplant therefore will not be enrolled on the study
• Inability to comply with the study and/or follow-up procedures.

Where it is running

• UF Health Cancer Hospital — Gainesville, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.